NCT06915350View on ClinicalTrials.gov

The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

January 31, 2029

Conditions
Maspin in Colorectal Carcinoma
Interventions
OTHER

maspin ( mammary serine protease inhibitor)

Maspin is an immunohistochemical marker to detect the prognosis of colorectal carcinoma

All Listed Sponsors
lead

Assiut University

OTHER

NCT06915350 - The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study | Biotech Hunter | Biotech Hunter